Replies to post #247993 on Biotech Values

[DewDiligence]

THRX goes private for $3.90-4.05/sh cash +CVR—essentially_no_premium_to_THRX’s_cash_value:

https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-enters-into-agreement-to-be-acquired-by-concentra-biosciences-for-between-3-90-and-4-05-in-cash-per-share-plus-a-contingent-value-right-302021402.html

The buyer is Concentra Biosciences a/k/a Tang Capital.

THRX has been a shell company since discontinuing its clinical program in Jul 2023 (#msg-172336650).